hepatitis c

Jun 17, 2025

Celltrion Announces FDA Nod for New STEQEYMA Presentation to Broaden Pediatric Use; CSL’s ANDEMBRY Gets FDA Nod as First Factor XIIa Inhibitor for Hereditary Angioedema; Ocugen’s OCU410ST Cleared by FDA to Begin Phase II/III Trial in Stargardt Disease; Milestone Pharmaceuticals Submits FDA Response for CARDAMYST in PSVT; AbbVie’s MAVYRET Approved by FDA as First and Only Therapy for Acute Hepatitis C

Dec 28, 2021

Biogen-Eisai’s Aduhelm; Quidel acquires Ortho Clinical Diagnostics; Accutar Biotechnology’s AC0176; Boehringer’s Spesolimab

Dec 14, 2020

Evolution in Hepatitis B and C Virus: Can we expect success similar to Hepatitis C in Hepatitis B as well?

May 26, 2020

Algernon’s NP-120; FDA nod to 4DMedical tool; SaNOtize’s NORSTM trial; Pole’s capital increase

Feb 19, 2020

Cardiovascular Disease: A major cause of health loss and a global burden

Oct 30, 2018

Notizia

Feb 14, 2018

Gilead Sciences Introduces Sovaldi: A Potent Hepatitis C Treatment

Mar 01, 2017

Hepatitis C drugs re-energize global fight over patents

Newsletter/Whitepaper